Publications by authors named "Bruce Silverstein"

Claim this Profile
E
Endogenous Endophthalmitis From Methicillin-Resistant Staphylococcus aureus Bacteremia Treated With Ceftaroline.
Daniel Ho, Nicola A Clayton, Bruce Silverstein, Alan Koff

Cureus· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of a Knowledge-Based Governance Approach to Plan a Post-COVID-19 Predoctoral Dental.
Natasha M Flake, Daniel C N Chan, Arthur C DiMarco, Bruce D Silverstein

Dent J (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Submicron loteprednol etabonate ophthalmic gel 0.38% for the treatment of inflammation and pain after cataract surgery.
Raymond Fong, Bruce E Silverstein, James H Peace, Jon I Williams, Jason L Vittitow

J Cataract Refract Surg· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis patients with Pseudomonas aeruginosa infections.
Bruce E Silverstein, Timothy W Morris, Lynne S Gearinger, Heleen H Decory, Timothy L Comstock

Clin Ophthalmol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis in adults and children.
Jesse DeLeon, Bruce E Silverstein, Catherine Allaire, Lynne S Gearinger, Kirk M Bateman

Clin Drug Investig· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of clinical efficacy and safety of tobramycin/dexamethasone ophthalmic suspension 0.3%/0.05% compared to azithromycin ophthalmic solution 1% in the treatment of moderate to severe acute blepharitis/blepharoconjunctivitis.
Gail L Torkildsen, Paul Cockrum, Edward Meier, William M Hammonds, Bruce Silverstein, Steven Silverstein

Curr Med Res Opin· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study in adults and children.
Bruce E Silverstein, Catherine Allaire, Kirk M Bateman, Lynne S Gearinger, Timothy W Morris

Clin Ther· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis